IVE Group - Appendix 4D and Half Year Results to 31 December 2022 (ASX:IGL) 23 Feb, 2023 09:41 AM To view the Appendix 4D and Half Year Results to 31 December 2022, download the attached PDF.
IVE Group - Half Year Financial Results - timing and conference call (ASX:IGL) 23 Feb, 2023 08:38 AM IVE Group Limited (ASX:IGL), intends releasing its financial results for the 6 months ending 31 December 2022 on Thursday 23rd February, 2023. Investors and analysts are invited to join a Zo...read more
INOVIQ - Positive results for SubB2M Breast Cancer Test (ASX:IIQ) 08 Feb, 2023 10:07 AM INOVIQ’s SubB2M-enhanced CA15.3 breast cancer test outperforms a leading commercially available CA15.3 tumour marker test Data from a 94-serum case-control study demonstrates...read more
Immutep - Enrolment Target Reached for INSIGHT-003 Trial in NSCLC (ASX:IMM) 06 Feb, 2023 10:32 AM 20 patients with 1st line non-small cell lung cancer (1L NSCLC) now enrolled in the first triple combination therapy study of efti with standard-of-care combination of anti-PD-1...read more
INOVIQ - Appendix 4C & Quarterly Activities Report - December 2022 (ASX:IIQ) 31 Jan, 2023 09:09 AM Highlights -- INOVIQ kicked off EXO-NET sales campaign in the US and reverted to a direct distribution model for hTERT sales in the US -- Contract Research Agreement signed with Nicoya to develo...read more
